A new biomaterial significantly reduces scar formation after wounding, leading to more effective skin healing, researchers report.
The new material, which quickly degrades once the wound has closed, demonstrates that activating an adaptive immune response can trigger regenerative wound healing, leaving behind stronger and healthier healed skin.
This work builds on the team’s previous research with hydrogel scaffolds, which create a structure to support tissue growth, accelerating wound healing. In their new study, the team showed that a modified version of the hydrogel activates a regenerative immune response, which can potentially help heal skin injuries like burns, cuts, diabetic ulcers, and other wounds that normally heal with significant scars that are more susceptible to reinjury.
Healing wounds with hydrogel
“The body forms scar tissue as fast as possible to reduce the chance of infection, to reduce pain, and, in larger wounds, to avoid water loss through evaporation,” says first author Maani Archang, an MD/PhD student in the labs of Philip Scumpia and Dino Di Carlo at the University of California, Los Angeles. “It’s a natural process of wound healing.”
Current wound-healing hydrogels available for clinical use sit on the surface of the wound, where they act as a dressing and help prevent the wound from drying out. That in turn helps the wound heal faster, generally via scar formation.
In a 2015 Nature Materials paper, the research team, helmed by Duke University’s Tatiana Segura and Di Carlo, developed microporous annealed particle (MAP) hydrogels, which are a microparticle-based biomaterial that can integrate into the wound rather than sit on the skin’s surface. The beads within the MAP gel link together but leave open spaces, creating a porous structure that provides a support for cells as they grow across the wound site. As the wound closes, the gel slowly dissolves, leaving behind healed skin.
Although the MAP hydrogels allowed for rapid cellular growth and faster repair, the team noticed that the healed skin had limited complex structures like hair follicles and sebaceous glands. The team was curious whether they could alter their biomaterial to improve the quality of the healed skin.
“Previously we’d seen that as the wound started to heal, the MAP gel started to lose porosity, which limited how the tissue could grow through the structure,” says first author Don Griffin, an assistant professor at the University of Virginia and a former postdoctoral fellow in the Segura Lab.
“We hypothesized that slowing down the degradation rate of the MAP scaffold would prevent the pores from closing and provide additional support to the tissue as it grows, which would improve the tissue’s quality.”
Rather than create an entirely new gel with new materials, the team instead focused on the chemical linker that allowed the scaffold to be naturally broken down by the body. In their original MAP gels, this chemical linker is composed of an amino acid sequence taken from the body’s own structural proteins and arranged in a chemical orientation called L chirality. Because this peptide sequence and orientation is common throughout the body, this helps the gel avoid triggering a strong immune response, but it also enables ready degradation through naturally present enzymes.
“Our body has evolved to recognize and degrade this amino acid structure, so we theorized that if we flipped the structure to its mirror image, which is D chirality, the body would have a harder time degrading the scaffold,” says Segura, a professor of biomedical engineering at Duke. “But when we put the hydrogel into a mouse wound, the updated gel ended up doing the exact opposite.”
The updated material integrated into the wound and supported the tissue as the wound closed. But instead of lasting longer, the team discovered that the new gel had almost entirely disappeared from the wound site, leaving behind just a few particles.
However, the healed skin turned out to be stronger and included complex skin structures that are typically absent in scars. After further investigation, the researchers discovered that the reason for the stronger healing—despite the lack of longevity—was a different immune response to the gel.
Guiding the immune response
After a skin injury, the body’s innate immune response is immediately activated to ensure that any foreign substances that enter the body are quickly destroyed. If substances can escape this first immune response, the body’s adaptive immune response kicks in, which identifies and targets the invading material with more specificity.
Because the original MAP gel was made with the common L peptide structure, it generated a mild innate immune response. But when the team placed the reformulated gel into a wound, the foreign D chirality activated the adaptive immune system, which created antibodies and activated cells including macrophages that targeted and cleared out the gel more quickly after the wound closed.
“There are two types of immune responses that can occur after injury—a destructive response and a more mild regenerative response,” says Scumpia, an assistant professor in the division of dermatology at UCLA Health and the West Los Angeles VA Medical Center. “When most biomaterials are placed in the body, they are walled off by the immune system and eventually degraded or destroyed. But in this study, the immune response to the gel induced a regenerative response in the healed tissue.”
“This study shows us that activating the immune system can be used to tilt the balance of wound healing from tissue destruction and scar formation to tissue repair and skin regeneration,” says Segura.
Working with Maksim Plikus, a regenerative tissue expert at the University of California, Irvine, the team also confirmed that key structures, like hair follicles and sebaceous glands, were correctly forming over the scaffold. When the team dug into the mechanism, they found that the cells of the adaptive immune system are required for this regenerative response.
As the team continues to study the regenerative immune response to their gel, they are also exploring the possibility of using the new MAP hydrogel as an immunomodulatory platform.
“The team is now exploring the best way to release immune signals from the gel to either induce skin regeneration or develop the hydrogel as a vaccine platform,” says Scumpia.
“I am excited about the possibility of designing materials that can directly interact with the immune system to support tissue regeneration” says Segura. “This is a new approach for us.”
The new research appears in Nature Materials.
The National Institutes of Health, the National Science Foundation, Simons Foundation Grants, the Pew Charitable Trust, and the LEO Foundation provided funding for the study. Donald Griffin, Westbrook Weaver, Di Carlo, Segura, and Scumpia have a financial interest in Tempo Therapeutics, which aims to commercialize MAP technology.
Source: Duke University